Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
February-2021 Volume 21 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2021 Volume 21 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Preventing oxaliplatin‑induced neuropathic pain: Using berberine to inhibit the activation of NF‑κB and release of pro‑inflammatory cytokines in dorsal root ganglions in rats

  • Authors:
    • Wan Ni
    • Xiaolan Zheng
    • Ling Hu
    • Chao Kong
    • Qingbang Xu
  • View Affiliations / Copyright

    Affiliations: Department of Pain Medicine, The Second Clinical Medical College, Yangtze University, Jingzhou, Hubei 434020, P.R. China, Department of Gastroenterology, The Fifth People's Hospital of Wuhan City, Wuhan, Hubei 430050, P.R. China, Department of Anesthesiology, Tianyou Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430064, P.R. China, Department of Anesthesiology, The Second Clinical Medical College, Yangtze University, Jingzhou, Hubei 434020, P.R. China, Department of Pain Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430032, P.R. China
  • Article Number: 135
    |
    Published online on: December 10, 2020
       https://doi.org/10.3892/etm.2020.9567
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Chemotherapy‑induced peripheral neuropathic pain (CIPNP) is a serious, undesirable effect of cancer treatment which is particularly difficult to prevent. Berberine and its derivatives have been reported to display robust antioxidant and analgesic effects in rat models of diabetic neuropathic pain and peripheral nerve injury. However, the analgesic role of berberine on oxaliplatin‑induced CIPNP remains unknown. The present study aimed to explore the analgesic effect of berberine on CIPNP. Sprague Dawley rats were used to create the CIPNP animal model by oxaliplatin administration. Behavioral tests were performed by von Frey test, acetone drop test, hot plate test, and motor coordination. The protein expression levels of NF‑κB p65 and phosphorylated p65 in dorsal root ganglions (DGRs) were detected by western blot analysis. Finally, TNF‑α and IL‑6 levels in DRGs were measured using specific ELISA kits. The results from the behavioral analysis demonstrated that a single injection of berberine ameliorated the mechanical and cold allodynia and thermal hyperalgesia in the model rats in a dose‑dependent manner. Cumulative administration of berberine prevented the mechanical and cold allodynia and thermal hyperalgesia in the development of CIPNP induced by oxaliplatin. This prophylactic effect of berberine was associated with reduced phosphorylation of p65 and with decreased levels of pro‑inflammatory cytokines IL‑6 and TNF‑α. The present study indicated that berberine may have a role in preventing the development of CIPNP and may serve as a therapeutic compound for the treatment of CIPNP.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Park SB, Goldstein D, Krishnan AV, Lin CS, Friedlander ML, Cassidy J, Koltzenburg M and Kiernan MC: Chemotherapy-induced peripheral neurotoxicity: A critical analysis. CA Cancer J Clin. 63:419–437. 2013.PubMed/NCBI View Article : Google Scholar

2 

Argyriou AA, Bruna J, Marmiroli P and Cavaletti G: Chemotherapy-induced peripheral neurotoxicity (CIPN): An update. Crit Rev Oncol Hematol. 82:51–77. 2012.PubMed/NCBI View Article : Google Scholar

3 

André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, et al: Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 350:2343–2351. 2004.PubMed/NCBI View Article : Google Scholar

4 

Cersosimo RJ: Oxaliplatin-associated neuropathy: A review. Ann Pharmacother. 39:128–135. 2005.PubMed/NCBI View Article : Google Scholar

5 

Farquhar-Smith P: Chemotherapy-induced neuropathic pain. Curr Opin Support Palliat Care. 5:1–7. 2011.PubMed/NCBI View Article : Google Scholar

6 

Brewer JR, Morrison G, Dolan ME and Fleming GF: Chemotherapy-induced peripheral neuropathy: Current status and progress. Gynecol Oncol. 140:176–183. 2016.PubMed/NCBI View Article : Google Scholar

7 

Vallabhapurapu S and Karin M: Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol. 27:693–733. 2009.PubMed/NCBI View Article : Google Scholar

8 

Meffert MK, Chang JM, Wiltgen BJ, Fanselow MS and Baltimore D: NF-kappa B functions in synaptic signaling and behavior. Nat Neurosci. 6:1072–1078. 2003.PubMed/NCBI View Article : Google Scholar

9 

Kaltschmidt B and Kaltschmidt C: NF-kappaB in the nervous system. Cold Spring Harb Perspect Biol. 1(a001271)2009.PubMed/NCBI View Article : Google Scholar

10 

Wan F, Anderson DE, Barnitz RA, Snow A, Bidere N, Zheng L, Hegde V, Lam LT, Staudt LM, Levens D, et al: Ribosomal protein S3: A KH domain subunit in NF-kappaB complexes that mediates selective gene regulation. Cell. 131:927–939. 2007.PubMed/NCBI View Article : Google Scholar

11 

Zhao LX, Jiang BC, Wu XB, Cao DL and Gao YJ: Ligustilide attenuates inflammatory pain via inhibition of NFκB-mediated chemokines production in spinal astrocytes. Eur J Neurosci. 39:1391–1402. 2014.PubMed/NCBI View Article : Google Scholar

12 

Chu LW, Chen JY, Wu PC and Wu BN: Atorvastatin prevents neuroinflammation in chronic constriction injury rats through nuclear NFκB downregulation in the dorsal root ganglion and spinal cord. ACS Chem Neurosci. 6:889–898. 2015.PubMed/NCBI View Article : Google Scholar

13 

Huang ZZ, Li D, Ou-Yang HD, Liu CC, Liu XG, Ma C, Wei JY, Liu Y and Xin WJ: Cerebrospinal fluid oxaliplatin contributes to the acute pain induced by systemic administration of oxaliplatin. Anesthesiology. 124:1109–1121. 2016.PubMed/NCBI View Article : Google Scholar

14 

Fu ES, Zhang YP, Sagen J, Candiotti KA, Morton PD, Liebl DJ, Bethea JR and Brambilla R: Transgenic inhibition of glial NF-kappaB reduces pain behavior and inflammation after peripheral nerve injury. Pain. 148:509–518. 2010.PubMed/NCBI View Article : Google Scholar

15 

Fu ES, Zhang YP, Sagen J, Yang ZQ and Bethea JR: Transgenic glial nuclear factor-kappaB inhibition decreases formalin pain in mice. Neuroreport. 18:713–717. 2007.PubMed/NCBI View Article : Google Scholar

16 

Nong X, Lan Y and Picroside II: Picroside II Attenuates CCI-induced neuropathic pain in rats by inhibiting spinal reactive astrocyte-mediated neuroinflammation through the NF-κB pathway. Neurochem Res. 43:1058–1066. 2018.PubMed/NCBI View Article : Google Scholar

17 

Tao W, Luo X, Cui B, Liang D, Wang C, Duan Y, Li X, Zhou S, Zhao M, Li Y, et al: Practice of traditional Chinese medicine for psycho-behavioral intervention improves quality of life in cancer patients: A systematic review and meta-analysis. Oncotarget. 6:39725–39739. 2015.PubMed/NCBI View Article : Google Scholar

18 

Yuan QL, Guo TM, Liu L, Sun F and Zhang YG: Traditional Chinese medicine for neck pain and low back pain: A systematic review and meta-analysis. PLoS One. 10(e0117146)2015.PubMed/NCBI View Article : Google Scholar

19 

Li Q, Yue N, Liu SB, Wang ZF, Mi WL, Jiang JW, Wu GC, Yu J, Wang YQ, et al: Effects of chronic electroacupuncture on depression- and anxiety-like behaviors in rats with chronic neuropathic pain. Evid Based Complement Alternat Med. 2014(158987)2014.PubMed/NCBI View Article : Google Scholar

20 

Chen C, Lu M, Pan Q, Fichna J, Zheng L, Wang K, Yu Z, Li Y, Li K, Song A, et al: Berberine improves intestinal motility and visceral pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome (IBS-D) symptoms in an opioid-receptor dependent manner. PLoS One. 10(e0145556)2015.PubMed/NCBI View Article : Google Scholar

21 

Chen C, Tao C, Liu Z, Lu M, Pan Q, Zheng L, Li Q, Song Z and Fichna J: A randomized clinical Trial of berberine hydrochloride in patients with diarrhea-predominant irritable bowel syndrome. Phytother Res. 29:1822–1827. 2015.PubMed/NCBI View Article : Google Scholar

22 

Tan W, Li Y, Chen M and Wang Y: Berberine hydrochloride: Anticancer activity and nanoparticulate delivery system. Int J Nanomedicine. 6:1773–1777. 2011.PubMed/NCBI View Article : Google Scholar

23 

Kim SO and Kim HJ: Berberine ameliorates cold and mechanical allodynia in a rat model of diabetic neuropathy. J Med Food. 16:511–517. 2013.PubMed/NCBI View Article : Google Scholar

24 

Han AM, Heo H and Kwon YK: Berberine promotes axonal regeneration in injured nerves of the peripheral nervous system. J Med Food. 15:413–417. 2012.PubMed/NCBI View Article : Google Scholar

25 

Rezaee R, Monemi A, SadeghiBonjar MA and Hashemzaei M: Berberine alleviates paclitaxel-induced neuropathy. J Pharmacopuncture. 22:90–94. 2019.PubMed/NCBI View Article : Google Scholar

26 

Sisignano M, Baron R, Scholich K and Geisslinger G: Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain. Nat Rev Neurol. 10:694–707. 2014.PubMed/NCBI View Article : Google Scholar

27 

Majithia N, Loprinzi CL and Smith TJ: New practical approaches to chemotherapy-induced neuropathic pain: Prevention, assessment, and treatment. Oncology (Williston Park). 30:1020–1029. 2016.PubMed/NCBI

28 

Liu M, Gao L and Zhang N: Berberine reduces neuroglia activation and inflammation in streptozotocin-induced diabetic mice. Int J Immunopathol Pharmacol. 33(2058738419866379)2019.PubMed/NCBI View Article : Google Scholar

29 

Ghosh S and Karin M: Missing pieces in the NF-kappaB puzzle. Cell. 109 (Suppl 1):S81–S96. 2002.PubMed/NCBI View Article : Google Scholar

30 

Vermeulen L, De Wilde G, Notebaert S, Vanden Berghe W and Haegeman G: Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. Biochem Pharmacol. 64:963–970. 2002.PubMed/NCBI View Article : Google Scholar

31 

Lu L, Hu J, Wu Q, An Y, Cui W, Wang J and Ye Z: Berberine prevents human nucleus pulposus cells from IL 1β induced extracellular matrix degradation and apoptosis by inhibiting the NF κB pathway. Int J Mol Med. 43:1679–1686. 2019.PubMed/NCBI View Article : Google Scholar

32 

Yoon SY and Oh J: Neuropathic cancer pain: Prevalence, pathophysiology, and management. Korean J Intern Med (Korean Assoc Intern Med). 33:1058–1069. 2018.PubMed/NCBI View Article : Google Scholar

33 

Carozzi VA, Canta A and Chiorazzi A: Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? Neurosci Lett. 596:90–107. 2015.PubMed/NCBI View Article : Google Scholar

34 

Ahmed AS, Berg S, Alkass K, Druid H, Hart DA, Svensson CI and Kosek E: NF-κB-associated pain-related neuropeptide expression in patients with degenerative disc disease. Int J Mol Sci. 20(20)2019.PubMed/NCBI View Article : Google Scholar

35 

Shih RH, Wang CY and Yang CM: NF-kappaB signaling pathways in neurological inflammation: A mini review. Front Mol Neurosci. 8(77)2015.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ni W, Zheng X, Hu L, Kong C and Xu Q: Preventing oxaliplatin‑induced neuropathic pain: Using berberine to inhibit the activation of NF‑κB and release of pro‑inflammatory cytokines in dorsal root ganglions in rats. Exp Ther Med 21: 135, 2021.
APA
Ni, W., Zheng, X., Hu, L., Kong, C., & Xu, Q. (2021). Preventing oxaliplatin‑induced neuropathic pain: Using berberine to inhibit the activation of NF‑κB and release of pro‑inflammatory cytokines in dorsal root ganglions in rats. Experimental and Therapeutic Medicine, 21, 135. https://doi.org/10.3892/etm.2020.9567
MLA
Ni, W., Zheng, X., Hu, L., Kong, C., Xu, Q."Preventing oxaliplatin‑induced neuropathic pain: Using berberine to inhibit the activation of NF‑κB and release of pro‑inflammatory cytokines in dorsal root ganglions in rats". Experimental and Therapeutic Medicine 21.2 (2021): 135.
Chicago
Ni, W., Zheng, X., Hu, L., Kong, C., Xu, Q."Preventing oxaliplatin‑induced neuropathic pain: Using berberine to inhibit the activation of NF‑κB and release of pro‑inflammatory cytokines in dorsal root ganglions in rats". Experimental and Therapeutic Medicine 21, no. 2 (2021): 135. https://doi.org/10.3892/etm.2020.9567
Copy and paste a formatted citation
x
Spandidos Publications style
Ni W, Zheng X, Hu L, Kong C and Xu Q: Preventing oxaliplatin‑induced neuropathic pain: Using berberine to inhibit the activation of NF‑κB and release of pro‑inflammatory cytokines in dorsal root ganglions in rats. Exp Ther Med 21: 135, 2021.
APA
Ni, W., Zheng, X., Hu, L., Kong, C., & Xu, Q. (2021). Preventing oxaliplatin‑induced neuropathic pain: Using berberine to inhibit the activation of NF‑κB and release of pro‑inflammatory cytokines in dorsal root ganglions in rats. Experimental and Therapeutic Medicine, 21, 135. https://doi.org/10.3892/etm.2020.9567
MLA
Ni, W., Zheng, X., Hu, L., Kong, C., Xu, Q."Preventing oxaliplatin‑induced neuropathic pain: Using berberine to inhibit the activation of NF‑κB and release of pro‑inflammatory cytokines in dorsal root ganglions in rats". Experimental and Therapeutic Medicine 21.2 (2021): 135.
Chicago
Ni, W., Zheng, X., Hu, L., Kong, C., Xu, Q."Preventing oxaliplatin‑induced neuropathic pain: Using berberine to inhibit the activation of NF‑κB and release of pro‑inflammatory cytokines in dorsal root ganglions in rats". Experimental and Therapeutic Medicine 21, no. 2 (2021): 135. https://doi.org/10.3892/etm.2020.9567
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team